Kent E. Lieginger
Director/Board Member at University of the Sciences in Philadelphia
Kent E. Lieginger active positions
| Companies | Position | Start | End |
|---|---|---|---|
| University of the Sciences in Philadelphia | Director/Board Member | 2012-12-31 | - |
Career history of Kent E. Lieginger
Former positions of Kent E. Lieginger
| Companies | Position | Start | End |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2003-12-31 | 2014-06-30 |
| The Genentech Foundation | Director/Board Member | 2004-12-31 | 2011-12-31 |
| University of California | Corporate Officer/Principal | - | - |
| GSK PLC | Corporate Officer/Principal | - | - |
| ACHAOGEN | Director/Board Member | 2015-03-12 | - |
| Independent Dir/Board Member | 2015-03-12 | - |
Statistics
International
| United States | 6 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
| The Genentech Foundation | Miscellaneous |
- Stock Market
- Insiders
- Kent E. Lieginger
- Experience